Apr 05, 2017 at 09:36 | Source: Moneycontrol.com
The transmission business of the company got an order worth Rs 432 crore in domestic market from PGCIL of 800 kV HVDC transmission line and construction & extension of 765/400 kV GIS/AIS substations.
Apr 05, 2017 at 08:20 | Source: PTI
The company bagged international orders worth Rs 1,270 crore for the transmission and distribution business while domestic orders are worth Rs 432, KEC International said in a BSE filing.
Mar 29, 2017 at 16:40 | Source: Moneycontrol.com
Edelweiss is bullish on KEC International has recommended buy rating on the stock with a target price of Rs 245 in its research report dated March 27, 2017.
Mar 29, 2017 at 10:35 | Source: Moneycontrol.com
The outlook for Indian market remains promising as it is still one of the better investment destination among the emerging market space.
Mar 07, 2017 at 07:54 | Source: CNBC-TV18
Shahina Mukadam, Independent Market Expert is of the view that one may buy Dishman Pharma with a target of Rs 245.
Mar 06, 2017 at 07:55 | Source: CNBC-TV18
Ashish Kyal of Waves Strategy Advisors is of the view that one may buy Havells India with a target of Rs 450.
Feb 05, 2017 at 11:58 | Source: PTI
With international oil and gas and commodity prices witnessing a decline, engineering firm KEC International is expecting its overseas business to pick and is eyeing nearly 45 per cent of its revenues from this, in fiscal 2017-18.
Feb 03, 2017 at 16:53 | Source: Moneycontrol.com
Centrum has recommended accumulate rating on KEC International with a target price of Rs 176 in its research report dated February 02, 2017.
Feb 02, 2017 at 15:27 | Source: Moneycontrol.com
HDFC Securities is bullish on KEC International has recommended buy rating on the stock with a target price of Rs 179 in its research report dated January 31, 2017.
Feb 02, 2017 at 13:01 | Source: CNBC-TV18
Increased allocation to railways and rural electrification in the Union Budget 2017 announced Wednesday will open up significant growth opportunities for KEC International, says MD & CEO Vimal Kejriwal.